Literature DB >> 2297761

Increased protein turnover despite normal energy metabolism and responses to feeding in patients with lung cancer.

S Melville1, M A McNurlan, A G Calder, P J Garlick.   

Abstract

We have examined the responses of energy and protein metabolism to nutrient intake in nine patients with lung carcinoma, of whom none were cachexic and only one had distant metastases, compared with nine control patients for elective aneurysm surgery, who were comparable in terms of age, body mass index, and smoking habits. Whole-body protein turnover and leucine oxidation were assessed by primed continuous infusion of L-[13C]leucine. Indirect calorimetry was used to determine energy expenditure and rates of carbohydrate and fat utilization. Lean body mass (LBM) was estimated from dilution of deuterium oxide. Measurements were made over an 8-h period, including 4 h postabsorptive followed by 4 h of feeding, during which small hourly meals were consumed. In the post-absorptive state, the rate of incorporation of leucine into protein was higher in the cancer group (mean +/- SD, cancer versus control: 102 +/- 21 versus 86 +/- 8 mumol/kg LBM/h, P less than 0.05), as was the release of leucine by protein degradation (126 +/- 19 versus 110 +/- 10 mumol/kg LBM/h, P less than 0.01), but there was no difference in rates of leucine oxidation (27 +/- 6 versus 27 +/- 5 mumol/kg LBM/h) or leucine balance (-25 +/- 7 versus -24 +/- 4 mumol/kg LBM/h). There were no differences between the cancer and control groups with respect to either resting energy expenditure (37.3 +/- 3.5 versus 35.2 +/- 3.8 kcal LBM/day) or the postabsorptive pattern of nutrient utilization (61 +/- 13% fat, 26 +/- 10% carbohydrate, and 13 +/- 2% protein versus 65 +/- 7%, 21 +/- 7%, and 14 +/- 2%, respectively). During feeding, leucine oxidation rose relative to the postabsorptive state, incorporation into protein remained the same, and release by protein degradation fell. Incorporation (106 +/- 20 versus 89 +/- 7 mumol/kg LBM/h, P less than 0.05) and release (59 +/- 12 versus 42 +/- 14 mumol/kg LBM/h, P less than 0.02) remained higher in the cancer group than in controls, but leucine oxidation (43 +/- 15 versus 43 +/- 12 mumol/kg LBM/h) and leucine balance (+48 +/- 10 versus +47 +/- 12 mumol/kg LBM/h) were the same. Energy expenditure during feeding increased to 43.8 +/- 5.1 versus 43.2 +/- 4.2 kcal/kg LBM/day, derived from 32 +/- 11% fat, 52 +/- 9% carbohydrate, and 16 +/- 5% protein in cancer patients and 36 +/- 7%, 48 +/- 8%, and 16 +/- 4%, respectively, in controls.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2297761

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  17 in total

1.  Protein synthesis rates in colon and liver: stimulation by gastrointestinal pathologies.

Authors:  S D Heys; K G Park; M A McNurlan; R A Keenan; J D Miller; O Eremin; P J Garlick
Journal:  Gut       Date:  1992-07       Impact factor: 23.059

2.  Whole body protein metabolism in children with cancer.

Authors:  S E Daley; A D Pearson; A W Craft; J Kernahan; R A Wyllie; L Price; C Brock; C Hetherington; D Halliday; K Bartlett
Journal:  Arch Dis Child       Date:  1996-10       Impact factor: 3.791

3.  Muscle mTORC1 suppression by IL-6 during cancer cachexia: a role for AMPK.

Authors:  James P White; Melissa J Puppa; Song Gao; Shuichi Sato; Stephen L Welle; James A Carson
Journal:  Am J Physiol Endocrinol Metab       Date:  2013-03-26       Impact factor: 4.310

4.  Total cellular glycomics allows characterizing cells and streamlining the discovery process for cellular biomarkers.

Authors:  Naoki Fujitani; Jun-ichi Furukawa; Kayo Araki; Tsuyoshi Fujioka; Yasuhiro Takegawa; Jinhua Piao; Taiki Nishioka; Tomohiro Tamura; Toshio Nikaido; Makoto Ito; Yukio Nakamura; Yasuro Shinohara
Journal:  Proc Natl Acad Sci U S A       Date:  2013-01-23       Impact factor: 11.205

Review 5.  Computational modeling of cancer cachexia.

Authors:  Kevin D Hall; Vickie E Baracos
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2008-05       Impact factor: 4.294

Review 6.  Role of specific dietary amino acids in clinical conditions.

Authors:  Renate Jonker; Mariëlle P K J Engelen; Nicolaas E P Deutz
Journal:  Br J Nutr       Date:  2012-08       Impact factor: 3.718

7.  Muscle protein waste in tumor-bearing rats is effectively antagonized by a beta 2-adrenergic agonist (clenbuterol). Role of the ATP-ubiquitin-dependent proteolytic pathway.

Authors:  P Costelli; C García-Martínez; M Llovera; N Carbó; F J López-Soriano; N Agell; L Tessitore; F M Baccino; J M Argilés
Journal:  J Clin Invest       Date:  1995-05       Impact factor: 14.808

Review 8.  Cancer cachexia.

Authors:  Michael J Tisdale
Journal:  Langenbecks Arch Surg       Date:  2004-05-28       Impact factor: 3.445

9.  Humoral mediation for cachexia in tumour-bearing rats.

Authors:  L Tessitore; P Costelli; F M Baccino
Journal:  Br J Cancer       Date:  1993-01       Impact factor: 7.640

10.  Mechanism of muscle protein degradation induced by a cancer cachectic factor.

Authors:  M J Lorite; M G Thompson; J L Drake; G Carling; M J Tisdale
Journal:  Br J Cancer       Date:  1998-10       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.